risperidone has been researched along with cyclohexanol in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 10 (62.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Albano, D; Amchin, J; Klockowski, PM; Taylor, KP; Zarycranski, W | 1 |
| Blass, DM; Pearson, VE | 1 |
| Ismail, M; Lyster, G | 1 |
| Blahak, C; Capelle, HH; Grips, E; Krauss, JK; Weigel, R; Wöhrle, JC | 1 |
| Albertson, T; Camilleri, C; Offerman, S | 1 |
| Kootstra-Ros, JE; van Baalen-Benedek, EH; van der Weide, J | 1 |
| Beljean, M; Cutroneo, P; Luu, RP; Siouffi, AM | 1 |
| Drummer, OH; Rodda, KE | 1 |
| Hendset, M; Hermann, M | 1 |
| Hinrichs, JW; Loovers, HM; Scholten, B; van der Weide, J | 1 |
| Dhir, A; Kulkarni, SK | 1 |
| Egerod, KL; Holst, B; Husum, H; Mellerup, E; Secher, A | 1 |
| Hegerl, U; Heinritz, W; Kopf, A; Strauss, M | 1 |
| Bundgaard, C; Garmer, M; Jensen, CJ | 1 |
| Cao, L; Chen, J; Fang, Y; Hong, W; Peng, D; Wu, Z; Yuan, C; Zhang, C | 1 |
| Eliasson, E; Haslemo, T; Lindh, JD; Mannheimer, B; Molden, E | 1 |
1 trial(s) available for risperidone and cyclohexanol
| Article | Year |
|---|---|
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Buspirone; China; Comorbidity; Cyclohexanols; Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant; Double-Blind Method; Female; Humans; Male; Middle Aged; Paroxetine; Remission Induction; Risperidone; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2013 |
15 other study(ies) available for risperidone and cyclohexanol
| Article | Year |
|---|---|
Effect of venlafaxine on the pharmacokinetics of risperidone.
Topics: Adult; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety; Area Under Curve; Cyclohexanols; Desvenlafaxine Succinate; Exploratory Behavior; Female; Humans; Isoxazoles; Male; Metabolic Clearance Rate; Middle Aged; Paliperidone Palmitate; Psychomotor Performance; Pyrimidines; Risperidone; Venlafaxine Hydrochloride | 1999 |
SIADH with multiple antidepressants in a geriatric patient.
Topics: Aged; Antidepressive Agents; Antipsychotic Agents; Bupropion; Cyclohexanols; Depressive Disorder; Humans; Inappropriate ADH Syndrome; Mianserin; Mirtazapine; Risperidone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2000 |
Treatment of psychotic depression associated with steroid therapy in Churg-Strauss syndrome.
Topics: Adrenal Cortex Hormones; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Churg-Strauss Syndrome; Cyclohexanols; Depression; Electroconvulsive Therapy; Female; Humans; Middle Aged; Paroxetine; Risperidone; Venlafaxine Hydrochloride | 2002 |
Risperidone-responsive segmental dystonia and pallidal deep brain stimulation.
Topics: Aged; Antidepressive Agents; Combined Modality Therapy; Cyclohexanols; Depression; Dopamine Antagonists; Dystonic Disorders; Electric Stimulation Therapy; Globus Pallidus; Humans; Male; Parkinson Disease, Secondary; Risperidone; Severity of Illness Index; Venlafaxine Hydrochloride | 2003 |
Fatal cerebral edema after moderate valproic acid overdose.
Topics: Adult; Ammonia; Brain Edema; Cyclohexanols; Drug Overdose; Fatal Outcome; Humans; Male; Risperidone; Valproic Acid; Venlafaxine Hydrochloride | 2005 |
Metabolic ratios of psychotropics as indication of cytochrome P450 2D6/2C19 genotype.
Topics: Alleles; Amitriptyline; Aryl Hydrocarbon Hydroxylases; Cyclohexanols; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Enzyme Activation; Gene Frequency; Genotype; Humans; Metabolic Clearance Rate; Mixed Function Oxygenases; Psychotropic Drugs; Risperidone; Venlafaxine Hydrochloride | 2005 |
Optimization of the separation of some psychotropic drugs and their respective metabolites by liquid chromatography.
Topics: Acetonitriles; Buffers; Chromatography, High Pressure Liquid; Cyclohexanols; Haloperidol; Hydrogen-Ion Concentration; Methanol; Models, Theoretical; Psychotropic Drugs; Risperidone; Solvents; Time Factors; Venlafaxine Hydrochloride | 2006 |
The redistribution of selected psychiatric drugs in post-mortem cases.
Topics: Antipsychotic Agents; Cyclohexanols; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Gastrointestinal Contents; Humans; Liver; Postmortem Changes; Risperidone; Selective Serotonin Reuptake Inhibitors; Tissue Distribution; Venlafaxine Hydrochloride | 2006 |
[Why measure drug metabolites?].
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Humans; Patient Compliance; Pharmaceutical Preparations; Pharmacogenetics; Risperidone; Venlafaxine Hydrochloride | 2007 |
Semi-quantitative CYP2D6 gene doses in relation to metabolic ratios of psychotropics.
Topics: Adolescent; Adult; Aged; Alleles; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Cyclohexanols; Cytochrome P-450 CYP2D6; Fluoxetine; Gene Dosage; Gene Frequency; Genotype; Humans; Middle Aged; Models, Genetic; Phenotype; Polymorphism, Genetic; Predictive Value of Tests; Psychotropic Drugs; Risperidone; Venlafaxine Hydrochloride; Young Adult | 2008 |
Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Immobility Response, Tonic; Locomotion; Male; Mice; Receptors, Adrenergic, alpha-2; Risperidone; Swimming; Venlafaxine Hydrochloride; Yohimbine | 2008 |
Risperidone treatment increases CB1 receptor binding in rat brain.
Topics: Adiponectin; Animals; Antipsychotic Agents; Brain; Cyclohexanols; Dopamine Antagonists; Eating; Ghrelin; Male; Motor Activity; Neuropeptide Y; Pro-Opiomelanocortin; Prolactin; Protein Binding; Raclopride; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Receptors, Ghrelin; Risperidone; RNA, Messenger; Tritium; Weight Gain | 2010 |
[Risperidone intoxication in a patient with a genetic predisposition as "poor [non]metabolizer"].
Topics: Adult; Antipsychotic Agents; Chromosomes, Human, Pair 22; Cyclohexanols; Cytochrome P-450 CYP2D6; Delusions; DNA Mutational Analysis; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Exons; Female; Genetic Carrier Screening; Humans; Inactivation, Metabolic; Introns; Metabolic Clearance Rate; Psychotic Disorders; Risperidone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2010 |
Species comparison of in vivo P-glycoprotein-mediated brain efflux using mdr1a-deficient rats and mice.
Topics: Animals; Aripiprazole; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Brain; Citalopram; Cyclohexanols; Gene Knockout Techniques; Genotype; Mice; Piperazines; Quinolones; Rats; Risperidone; Species Specificity; Venlafaxine Hydrochloride | 2012 |
Risperidone and Venlafaxine Metabolic Ratios Strongly Predict a CYP2D6 Poor Metabolizing Genotype.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Child; Cyclohexanols; Cytochrome P-450 CYP2D6; Desvenlafaxine Succinate; Female; Genotype; Humans; Male; Middle Aged; Paliperidone Palmitate; Predictive Value of Tests; Retrospective Studies; Risperidone; Sensitivity and Specificity; Venlafaxine Hydrochloride; Young Adult | 2016 |